SenesTech (NASDAQ:SNES) Now Covered by StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNESGet Free Report) in a note issued to investors on Wednesday. The firm set a “sell” rating on the stock.

SenesTech Price Performance

Shares of NASDAQ SNES opened at $2.28 on Wednesday. The company has a current ratio of 4.68, a quick ratio of 3.49 and a debt-to-equity ratio of 0.05. SenesTech has a 12 month low of $1.90 and a 12 month high of $53.28. The stock has a 50 day moving average of $3.15 and a 200-day moving average of $5.33.

SenesTech (NASDAQ:SNESGet Free Report) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($3.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($3.20) by $0.12. SenesTech had a negative return on equity of 168.64% and a negative net margin of 464.09%. The business had revenue of $0.46 million during the quarter, compared to the consensus estimate of $0.49 million. During the same quarter last year, the firm posted ($84.03) EPS. On average, equities analysts expect that SenesTech will post -11 earnings per share for the current fiscal year.

SenesTech Company Profile

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Featured Articles

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.